2020 Award Submission Extended!
Submission Deadline Extended
October 9th, 2020
Nominations Solicited for 2020 Alvin R. Tarlov & John E. Ware Jr. Doctoral Dissertation and Post- Doctoral Awards in Patient-Reported Outcomes
The Board of Directors of the Health Assessment Laboratory (HAL) is pleased to announce the solicitation of
applications for the 2020-2021 cycle of the Alvin R. Tarlov & John E. Ware Jr. Doctoral Dissertation and Post-
Doctoral Awards in Patient-Reported Outcomes. The purpose of these awards is to encourage doctoral
dissertations and post-doctoral research using patient-reported outcomes. We envision up to two (2) total
awards being given for the 2020-21 academic year, with each award being for $25,000 ($20,000 made in
September 2020, and an additional $5,000 upon receipt of a satisfactory progress report submitted between
May 1, 2021 and September 1, 2021). Eligibility for the 2020-21 academic year is limited to U.S. citizens
enrolled in U.S. based doctoral programs or post-doctoral fellowships in U.S. research programs.
This award is named in honor of the Health Assessment Laboratory's founders, Dr. Alvin Tarlov and Dr. John Ware, Jr. - two of the world's leading pioneers in the development and use of patient-reported outcome measures. The Health Assessment Lab is a freestanding not-for-profit organization with the goal of advancing state-of-the-art tools for monitoring health care services and health outcomes from the patient/consumer point of view. Historically it has had four missions: development and validation of new measures; translation and adaptation of tools for use in international research; technical assistance in support of patient-based tools in a variety of specific applications; and education and training in psychometrics as applied to the health care field.
The Selection Committee for 2020-21 is chaired by Professor Eugene Nelson, DSc, a HAL Board Member,
Director of the Population Health Measurement Program at The Dartmouth Institute for Health Policy and
Clinical Practice, and Professor of Community and Family Medicine at Geisel School of Medicine at
Dartmouth College. Other members of the selection committee include: Shelly Greenfield, MD (UC -Irvine),
Lewis Kazis, DrPH (Boston U), Sherry Kaplan, PhD (UC-Irvine), Susan Yount, PhD (Northwestern), and Lisa
Zubkoff, PhD (VA). Members of the selection committee will be required to recuse themselves from
discussions and votes on any applicants from their home institution or any affiliated entities.
Fundable proposals will be dissertations or post-doctoral research projects that use patient-reported outcomes
(PROs) as a dependent variable. Patient-reported outcome measures that will be considered include: (a) PROMs:
patient-reported outcome measures related to symptoms, health status and health-related quality of life, and (b)
PREMs: patient-reported experience measures related to a patient’s experiences in seeking healthcare or in using
healthcare services such as access, communication, caring and concern, patient-clinician relationship, shared
decision-making, engagement in care planning, continuity, etc.
The review process will not include Pink Sheet-like critiques; the review adopts the Robert Wood Johnson
Foundation policy of only providing decisions. Applicants may apply more than once.
Documents required for 2020-21 applications:
1. Cover letter including a brief description of yourself and your project, as well as:
a. Name of degree-granting institution and program, including contact information
b. Name and contact information of dissertation advisor
2. CV (including school email address, personal email address, and other contact information)
3. Two recommendations (including one from dissertation advisor)
4. 8-10 page narrative (excluding appendices) on the dissertation, including the:
b. Overall aims of proposed work
c. Specific research questions
d. Conceptual framework or model
e. Proposed methods for work
f. Importance or implications of using patient reported outcomes (as a dependent variable)
The application should be on standard paper size (8.5” x 11”). Use at least one-half inch margins (top, bottom,
left, and right) for all pages. Use an Arial or Helvetica typeface and a font size of 11 or 12 points. The text of the
application should be single-spaced. Use headings and sub-headings to separate sections and label tables and
Questions regarding the application process or content can be sent to or visit
the HAL website at
Application due date: October 9, 2020
(before midnight Eastern Standard Time).
Please submit the application
via email to email@example.com.
Dr. Eugene Nelson, Chair, Selection Committee, and Member, Board of Directors, Health Assessment
Laboratory, Dr. Lisa Zubkoff, President, Board of Directors, Health Assessment Laboratory